세계의 수익 주기 관리 시장 : 시장 규모, 점유율 및 동향 분석(제품별, 유형별, 제공 방식별, 최종 용도별, 지역별), 부문별 예측(2025-2033년)

Revenue Cycle Management Market Summary

The global revenue cycle management market size was estimated at USD 343.78 billion in 2024 and is projected to reach USD 894.25 billion by 2033, growing at a CAGR of 11.12% from 2025 to 2033. The healthcare industry is rapidly moving towards digitalization, creating demand for advanced revenue cycle management (RCM) solutions.

The increasing number of data silos and unorganized workflows in healthcare settings is leading to market development and growth. RCM involves third-party payers, payment models, guidelines, and codes. The success of a healthcare practice depends on obtaining the right assets. As payment for medical services becomes more complex, it becomes increasingly valuable to have an efficient RCM solution.

The revenue cycle management industry growth in healthcare organizations is expected to be driven by the increasing demand for workflow optimization with the adoption of synchronized management software systems. The healthcare industry is constantly evolving with regular technological advancements, and as a result, many healthcare payers and providers are rapidly adopting these advancements. For instance, in November 2023, the Healthcare Financial Management Association (HFMA) partnered with FinThrive, Inc. to launch a five-stage RCM technology adoption model (RCMTAM). This model helps health systems assess current RCM technology maturity and build best-practice plans using industry benchmarks.

Moreover, innovations and advancements in the RCM solutions have played a key role in improving provider-patient relations and include the implementation of ICD-10 for classifying, coding, and reporting data on disease diagnosis and treatment procedures, which directly helps healthcare systems enhance care delivery. Healthcare facilities are outsourcing RCM software solutions owing to the multiple advantages associated such as easy availability of trained and skilled professionals, enhanced efficiency, compliance, and adherence to required regulations, and cost-effectiveness.

A survey by Salucro Healthcare Solutions in January 2024, involving 176 healthcare professionals, found that 50% of respondents are generally satisfied with their organization's revenue cycle management, with 34% considering it somewhat efficient and 16% very efficient. However, hands-on revenue cycle leaders are less likely to view the system as efficient compared to executive leaders. Timely patient collections, staff hiring/training, managing denials, security/compliance, and data analytics/reporting are key challenges.

Moreover, increasing initiatives and investments supporting healthcare IT, mHealth, and digital health are receiving significant support from venture capitalists, private equity firms, and healthcare organizations. The global landscape of health-tech investment experienced a substantial surge in 2021, surpassing USD 44 billion, marking a twofold increase compared to the previous year. This influx of capital highlights the increasing significance of technological innovation in healthcare. Noteworthy is the emergence of major tech-enabled platform companies as key players, offering the potential to improve hospital and health system efficiencies, swiftly expand operations, and modernize existing systems and delivery models. Furthermore, these platforms are poised to play a crucial role in addressing concerns regarding health equity through a comprehensive and inclusive approach to healthcare delivery.

Global Revenue Cycle Management Market Report Segmentation

This report forecasts revenue growth at the global, regional & country level and provides an analysis of the latest trends and opportunities in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the revenue cycle management market report based on product, type, delivery mode, end use, and region:

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Software
• Services
• Type (Revenue, USD Million, 2021 - 2033)
• Integrated
• Standalone
• Delivery Mode Outlook (Revenue, USD Million, 2021 - 2033)
• Web-based
• Cloud-based
• On-premise
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Physician Back Offices
• Hospitals
• Diagnostic Laboratories
• Other
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East and Africa (MEA)
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Product
  • 1.2.3. Delivery Mode
  • 1.2.4. End Use
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Segmentation and Scope
• 3.2. Market Lineage Outlook
  • 3.2.1. Parent Market Outlook
  • 3.2.2. Related/Ancillary Market Outlook
• 3.3. Market Trends and Outlook
• 3.4. Market Driver Analysis
  • 3.4.1. Increasing Outsourcing of Revenue Cycle Management
  • 3.4.2. Technological Advancement
  • 3.4.3. Adoption of integrated EHR/RCM system among healthcare facilities
• 3.5. Market Restraint Analysis
  • 3.5.1. Lack of Professionals to Handle RCM Processes
  • 3.5.2. Increasing Payer Partnerships
• 3.6. Business Environment Analysis
  • 3.6.1. PESTLE Analysis
  • 3.6.2. Porter's Five Forces Analysis
• 3.7. COVID-19 Impact Analysis
• 3.8. Case Studies
• 3.9. Notable RCM M&A Transactions
• 3.10. Private Equity Investment in RCM Companies
• 3.11. Major Deals & Strategic Alliances

Chapter 4. Revenue Cycle Management Market: Product Estimates & Trend Analysis

• 4.1. Revenue Cycle Management Market: Product Movement Analysis and Market Share
• 4.2. Revenue Cycle Management Market: Segment Dashboard
• 4.3. Software
  • 4.3.1. Software market, 2021 - 2033 (USD Million)
• 4.4. Services
  • 4.4.1. Services market, 2021 - 2033 (USD Million)

Chapter 5. Revenue Cycle Management Market: Management Type Estimates & Trend Analysis

• 5.1. Revenue Cycle Management Market: Management Type Movement Analysis and Market Share
• 5.2. Revenue Cycle Management Market: Segment Dashboard
• 5.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 5.4. Integrated
  • 5.4.1. Integrated market, 2021 - 2033 (USD Million)
• 5.5. Standalone
  • 5.5.1. Standalone market, 2021 - 2033 (USD Million)

Chapter 6. Revenue Cycle Management Market: Delivery Mode Type Estimates & Trend Analysis

• 6.1. Revenue Cycle Management Market: Delivery Mode Type Movement Analysis and Market Share
• 6.2. Revenue Cycle Management Market: Segment Dashboard
• 6.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 6.4. On-premise
  • 6.4.1. On-premise market, 2021 - 2033 (USD Million)
• 6.5. Web-based
  • 6.5.1. Web-based market, 2021 - 2033 (USD Million)
• 6.6. Cloud-based
  • 6.6.1. Cloud-based market, 2021 - 2033 (USD Million)

Chapter 7. Revenue Cycle Management Market: End Use Estimates & Trend Analysis

• 7.1. Revenue Cycle Management Market: End Use Movement Analysis and Market Share
• 7.2. Revenue Cycle Management Market: Segment Dashboard
• 7.3. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
• 7.4. Physician Back Offices
  • 7.4.1. Physician back offices market, 2021 - 2033 (USD Million)
• 7.5. Hospitals
  • 7.5.1. Hospitals market, 2021 - 2033 (USD Million)
• 7.6. Diagnostic Laboratories
  • 7.6.1. Diagnostic laboratories market, 2021 - 2033 (USD Million)
• 7.7. Others
  • 7.7.1. Others market, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis

• 8.1. Regional Market Share Analysis, 2024 & 2033
• 8.2. Regional Market Dashboard
• 8.3. Global Regional Market Snapshot
• 8.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
• 8.5. North America
  • 8.5.1. North America Revenue Cycle Management Market, 2021 - 2033 (USD Million)
  • 8.5.2. U.S.
    • 8.5.2.1. Key Country Dynamic
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Regulatory Framework
    • 8.5.2.4. U.S. revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.5.3. Canada
    • 8.5.3.1. Key Country Dynamic
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. Regulatory Framework
    • 8.5.3.4. Canada revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.5.4. Mexico
    • 8.5.4.1. Key Country Dynamic
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. Mexico revenue cycle management market, 2021 - 2033 (USD Million)
• 8.6. Europe
  • 8.6.1. Europe Revenue Cycle Management Market, 2021 - 2033 (USD Million)
  • 8.6.2. Germany
    • 8.6.2.1. Key Country Dynamic
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Germany revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.6.3. UK
    • 8.6.3.1. Key Country Dynamic
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. UK revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.6.4. France
    • 8.6.4.1. Key Country Dynamic
    • 8.6.4.2. Competitive Scenario
    • 8.6.4.3. Regulatory Framework
    • 8.6.4.4. France revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1. Key Country Dynamic
    • 8.6.5.2. Competitive Scenario
    • 8.6.5.3. Regulatory Framework
    • 8.6.5.4. Italy revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1. Key Country Dynamic
    • 8.6.6.2. Competitive Scenario
    • 8.6.6.3. Regulatory Framework
    • 8.6.6.4. Spain revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.6.7. Denmark
    • 8.6.7.1. Key Country Dynamic
    • 8.6.7.2. Competitive Scenario
    • 8.6.7.3. Regulatory Framework
    • 8.6.7.4. Denmark revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1. Key Country Dynamic
    • 8.6.8.2. Competitive Scenario
    • 8.6.8.3. Regulatory Framework
    • 8.6.8.4. Sweden revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.6.9. Norway
    • 8.6.9.1. Key Country Dynamic
    • 8.6.9.2. Competitive Scenario
    • 8.6.9.3. Regulatory Framework
    • 8.6.9.4. Norway revenue cycle management market, 2021 - 2033 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Asia Pacific Revenue Cycle Management Market, 2021 - 2033 (USD Million)
  • 8.7.2. Japan
    • 8.7.2.1. Key Country Dynamic
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. Japan revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.7.3. China
    • 8.7.3.1. Key Country Dynamic
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. China revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.7.4. India
    • 8.7.4.1. Key Country Dynamic
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. India revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1. Key Country Dynamic
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. South Korea revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.7.6. Australia
    • 8.7.6.1. Key Country Dynamic
    • 8.7.6.2. Competitive Scenario
    • 8.7.6.3. Regulatory Framework
    • 8.7.6.4. Australia revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.7.7. Thailand
    • 8.7.7.1. Key Country Dynamic
    • 8.7.7.2. Competitive Scenario
    • 8.7.7.3. Regulatory Framework
    • 8.7.7.4. Thailand revenue cycle management market, 2021 - 2033 (USD Million)
• 8.8. Latin America
  • 8.8.1. Latin America Revenue Cycle Management Market, 2021 - 2033 (USD Million)
  • 8.8.2. Brazil
    • 8.8.2.1. Key Country Dynamic
    • 8.8.2.2. Competitive Scenario
    • 8.8.2.3. Regulatory Framework
    • 8.8.2.4. Brazil revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.8.3. Argentina
    • 8.8.3.1. Key Country Dynamic
    • 8.8.3.2. Competitive Scenario
    • 8.8.3.3. Regulatory Framework
    • 8.8.3.4. Argentina revenue cycle management market, 2021 - 2033 (USD Million)
• 8.9. MEA
  • 8.9.1. MEA Revenue Cycle Management Market, 2021 - 2033 (USD Million)
  • 8.9.2. South Africa
    • 8.9.2.1. Key Country Dynamic
    • 8.9.2.2. Competitive Scenario
    • 8.9.2.3. Regulatory Framework
    • 8.9.2.4. South Africa revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.9.3. Saudi Arabia
    • 8.9.3.1. Key Country Dynamic
    • 8.9.3.2. Competitive Scenario
    • 8.9.3.3. Regulatory Framework
    • 8.9.3.4. Saudi Arabia revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.9.4. UAE
    • 8.9.4.1. Key Country Dynamic
    • 8.9.4.2. Competitive Scenario
    • 8.9.4.3. Regulatory Framework
    • 8.9.4.4. UAE revenue cycle management market, 2021 - 2033 (USD Million)
  • 8.9.5. Kuwait
    • 8.9.5.1. Key Country Dynamic
    • 8.9.5.2. Competitive Scenario
    • 8.9.5.3. Regulatory Framework
    • 8.9.5.4. Kuwait revenue cycle management market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Participant's Overview
• 9.2. Financial Performance
• 9.3. Estimated Company Market Share Analysis, 2024 (%)
• 9.4. Company Market Position Analysis
• 9.5. Strategy Mapping
  • 9.5.1. Expansion
  • 9.5.2. Acquisition
  • 9.5.3. Collaborations
  • 9.5.4. New Product Launches
  • 9.5.5. Partnerships
  • 9.5.6. Others
• 9.6. Company Profiles
  • 9.6.1. The SSI Group, Inc.
    • 9.6.1.1. Overview
    • 9.6.1.2. Financial Performance
    • 9.6.1.3. Product Benchmarking
    • 9.6.1.4. Strategic Initiatives
  • 9.6.2. Veradigm LLC (AllScripts Healthcare, LLC)
    • 9.6.2.1. Overview
    • 9.6.2.2. Financial Performance
    • 9.6.2.3. Product Benchmarking
    • 9.6.2.4. Strategic Initiatives
  • 9.6.3. Oracle (Cerner Corporation)
    • 9.6.3.1. Overview
    • 9.6.3.2. Financial Performance
    • 9.6.3.3. Product Benchmarking
    • 9.6.3.4. Strategic Initiatives
  • 9.6.4. McKesson Corporation
    • 9.6.4.1. Overview
    • 9.6.4.2. Financial Performance
    • 9.6.4.3. Product Benchmarking
    • 9.6.4.4. Strategic Initiatives
  • 9.6.5. Athenahealth, Inc.
    • 9.6.5.1. Overview
    • 9.6.5.2. Financial Performance
    • 9.6.5.3. Product Benchmarking
    • 9.6.5.4. Strategic Initiatives
  • 9.6.6. Epic Systems Corporation
    • 9.6.6.1. Overview
    • 9.6.6.2. Financial Performance
    • 9.6.6.3. Product Benchmarking
    • 9.6.6.4. Strategic Initiatives
  • 9.6.7. NXGN Management, LLC
    • 9.6.7.1. Overview
    • 9.6.7.2. Financial Performance
    • 9.6.7.3. Product Benchmarking
    • 9.6.7.4. Strategic Initiatives
  • 9.6.8. CareCloud Corporation
    • 9.6.8.1. Overview
    • 9.6.8.2. Financial Performance
    • 9.6.8.3. Product Benchmarking
    • 9.6.8.4. Strategic Initiatives
  • 9.6.9. Quest Diagnostics, Inc.
    • 9.6.9.1. Overview
    • 9.6.9.2. Financial Performance
    • 9.6.9.3. Product Benchmarking
    • 9.6.9.4. Strategic Initiatives
  • 9.6.10. Experian Information Solutions, Inc.
    • 9.6.10.1. Overview
    • 9.6.10.2. Financial Performance
    • 9.6.10.3. Product Benchmarking
    • 9.6.10.4. Strategic Initiatives
  • 9.6.11. R1 RCM, Inc.
    • 9.6.11.1. Overview
    • 9.6.11.2. Financial Performance
    • 9.6.11.3. Product Benchmarking
    • 9.6.11.4. Strategic Initiatives